Hemogenyx Pharmaceuticals Plc
(LSE) HEMO
Hemogenyx Pharmaceuticals Plc Financials at a Glance
Market Cap
$6.17B
Revenue (TTM)
$0.00
Net Income (TTM)
$10.18M
EPS (TTM)
$-221.60
P/E Ratio
-4.33
Dividend
$0.00
Beta (Volatility)
0.04 (Low)
Dividend
$0.00
Beta (Volatility)
0.04 (Low)
Price
$960.00
Volume
20,279
Open
$919.00
Price
$960.00
Volume
20,279
Open
$919.00
Previous Close
$960.00
Daily Range
$918.05 - $999.00
52-Week Range
$124.27 - $1800.00
Dividend
$0.00
Beta (Volatility)
0.04 (Low)
Price
$960.00
Volume
20,279
Open
$919.00
Previous Close
$960.00
Daily Range
$918.05 - $999.00
52-Week Range
$124.27 - $1800.00
HEMO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hemogenyx Pharmaceuticals Plc
Industry
Biotechnology
Sector
Health CareEmployees
22
CEO
Vladislav Sandler, PhD
Website
www.hemogenyx.comHeadquarters
London, EC3V 0HR, GB
HEMO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-609%
Return on Capital
-3%
Return on Assets
-3%
Earnings Yield
-23.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.17B
Shares Outstanding
6.43M
Volume
20.28K
Short Interest
0.00%
Avg. Volume
28.63K
Financials (TTM)
Gross Profit
$639.28K
Operating Income
$5.73M
EBITDA
$4.71M
Operating Cash Flow
$4.12M
Capital Expenditure
$13.28K
Free Cash Flow
$4.13M
Cash & ST Invst.
$159.26K
Total Debt
$2.62M
Hemogenyx Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$313.78K
+1.9%
Gross Margin
0.00%
N/A
Market Cap
$6.17B
N/A
Market Cap/Employee
$385.53M
N/A
Employees
16
N/A
Net Income
$5.00M
-15.8%
EBITDA
$4.57M
-19.0%
Quarterly Fundamentals
Net Cash
$1.98M
-996.9%
Accounts Receivable
$343.09K
+328.3%
Inventory
$0.00
+100.0%
Long Term Debt
$1.79M
-36.5%
Short Term Debt
$827.03K
+84.7%
Return on Assets
-2.52%
N/A
Return on Invested Capital
-2.96%
N/A
Free Cash Flow
$3.79M
-13.3%
Operating Cash Flow
$3.78M
-13.6%